Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipocalin 12 is a member of the lipocalin family, a group of small extracellular proteins characterized by a highly conserved β-barrel structure that encloses a ligand-binding site[1][2][3][4]. Lipocalins, including LCN12, typically function as transport proteins, binding and carrying small hydrophobic molecules such as lipids, steroids, and retinoids through body fluids[1][2][3]. They also play roles in immune modulation, regulation of cell homeostasis, and may be involved in various pathophysiological processes, including cancer and inflammation, based on broader evidence for the lipocalin family[1][2][4]. The specific biological and disease roles of LCN12 remain less studied than some other family members such as LCN2, but expression analyses suggest it is present in certain human tissues and may be involved in processes relevant to disease[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipocalin 12 (LCN12).